Taro Pharmaceutical Industries ROE 2006-2018 | TARO

Current and historical return on equity (ROE) values for Taro Pharmaceutical Industries (TARO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Taro Pharmaceutical Industries ROE for the three months ending September 30, 2018 was 11.99%.
Taro Pharmaceutical Industries ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.23B $2.35B 10.35%
2018-06-30 $0.22B $2.28B 10.02%
2018-03-31 $0.21B $2.21B 9.58%
2017-12-31 $0.21B $2.20B 9.59%
2017-09-30 $0.33B $2.21B 15.61%
2017-06-30 $0.40B $2.15B 19.70%
2017-03-31 $0.46B $2.07B 23.10%
2016-12-31 $0.49B $2.00B 25.15%
2016-09-30 $0.54B $1.92B 27.90%
2016-06-30 $0.55B $1.92B 29.53%
2016-03-31 $0.54B $1.94B 30.83%
2015-12-31 $0.58B $1.94B 35.57%
2015-09-30 $0.53B $1.62B 36.09%
2015-06-30 $0.54B $1.53B 39.55%
2015-03-31 $0.48B $1.42B 38.42%
2014-12-31 $0.42B $1.32B 36.36%
2014-09-30 $0.40B $1.20B 37.09%
2014-06-30 $0.35B $1.09B 33.96%
2014-03-31 $0.36B $1.02B 36.57%
2013-12-31 $0.32B $0.95B 33.52%
2013-09-30 $0.29B $1.04B 31.53%
2013-06-30 $0.26B $0.94B 30.50%
2013-03-31 $0.27B $0.89B 33.41%
2012-12-31 $0.26B $0.85B 36.20%
2012-09-30 $0.24B $0.76B 35.91%
2012-06-30 $0.23B $0.69B 38.79%
2012-03-31 $0.20B $0.62B 37.83%
2011-12-31 $0.18B $0.57B 37.44%
2011-09-30 $0.13B $0.50B 28.36%
2011-06-30 $0.09B $0.46B 21.82%
2011-03-31 $0.07B $0.42B 20.09%
2010-12-31 $0.05B $0.38B 17.61%
2010-09-30 $0.06B $0.30B 22.69%
2010-06-30 $0.05B $0.26B 20.60%
2010-03-31 $0.04B $0.25B 18.57%
2009-12-31 $0.03B $0.24B 15.05%
2009-09-30 $0.04B $0.23B 18.87%
2009-06-30 $0.04B $0.21B 20.85%
2009-03-31 $0.03B $0.20B 15.50%
2008-12-31 $0.03B $0.21B 17.74%
2008-09-30 $0.02B $0.21B 9.90%
2007-12-31 $-0.00B $0.19B -1.58%
2006-12-31 $-0.00B $0.10B -0.42%
2006-03-31 $0.01B $0.24B 1.62%
2005-12-31 $0.01B $0.24B 1.46%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.937B $0.662B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.371B 11.43
Zoetis (ZTS) United States $44.331B 30.35
Grifols (GRFS) Spain $14.524B 17.73
Tilray (TLRY) United States $10.290B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.614B 12.36
Neurocrine Biosciences (NBIX) United States $8.160B 1799.60
Ionis Pharmaceuticals (IONS) United States $7.393B 0.00
Nektar Therapeutics (NKTR) United States $6.617B 9.49
Catalent (CTLT) United States $5.726B 24.02
Impax Laboratories (AMRX) United States $5.526B 29.38
Sage Therapeutics (SAGE) United States $5.355B 0.00
United Therapeutics (UTHR) United States $5.295B 8.66
Loxo Oncology (LOXO) United States $4.792B 0.00
FibroGen (FGEN) United States $3.437B 0.00
USANA Health Sciences (USNA) United States $2.884B 24.55
Endo (ENDP) Ireland $2.847B 4.36
Xencor (XNCR) United States $2.239B 0.00
Heron Therapeutics (HRTX) United States $2.084B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.000B 0.00
Aerie Pharmaceuticals (AERI) United States $1.949B 0.00
Endocyte (ECYT) United States $1.943B 0.00
TESARO (TSRO) United States $1.924B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.924B 260.00
Ironwood Pharmaceuticals (IRWD) United States $1.846B 0.00
PTC Therapeutics (PTCT) United States $1.711B 0.00
Zogenix (ZGNX) United States $1.710B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.573B 19.24
Corcept Therapeutics (CORT) United States $1.503B 22.07
Theravance Biopharma (TBPH) Cayman Islands $1.454B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.413B 0.00
Portola Pharmaceuticals (PTLA) United States $1.329B 0.00
Tricida (TCDA) United States $1.318B 0.00
Esperion Therapeutics (ESPR) United States $1.300B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.179B 0.00
TherapeuticsMD (TXMD) United States $1.158B 0.00
ImmunoGen (IMGN) United States $0.892B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.863B 0.00
Radius Health (RDUS) United States $0.761B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.690B 0.00
Karyopharm Therapeutics (KPTI) United States $0.678B 0.00
Flexion Therapeutics (FLXN) United States $0.638B 0.00
Collegium Pharmaceutical (COLL) United States $0.578B 0.00
GlycoMimetics (GLYC) United States $0.515B 0.00
ChemoCentryx (CCXI) United States $0.514B 40.68
Rigel Pharmaceuticals (RIGL) United States $0.477B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.468B 0.00
Akebia Therapeutics (AKBA) United States $0.455B 0.00
Siga Technologies (SIGA) United States $0.448B 0.00
Odonate Therapeutics (ODT) United States $0.443B 0.00
Xeris Pharmaceuticals (XERS) United States $0.439B 0.00
Dova Pharmaceuticals (DOVA) United States $0.437B 0.00
ArQule (ARQL) United States $0.436B 0.00
OptiNose (OPTN) United States $0.425B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 24.96
Aquestive Therapeutics (AQST) United States $0.421B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.412B 0.00
Dermira (DERM) United States $0.409B 0.00
Forty Seven (FTSV) United States $0.404B 0.00
CASI Pharmaceuticals (CASI) United States $0.391B 0.00
Zafgen (ZFGN) United States $0.364B 0.00
Aclaris Therapeutics (ACRS) United States $0.361B 0.00
Depomed (ASRT) United States $0.351B 13.07
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.346B 0.00
Mast Therapeutics (SVRA) United States $0.330B 0.00
Tapimmune (MRKR) United States $0.329B 0.00
Minerva Neurosciences (NERV) United States $0.327B 0.00
KalVista Pharmaceuticals (KALV) United States $0.324B 0.00
Aratana Therapeutics (PETX) United States $0.319B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.317B 0.00
Concert Pharmaceuticals (CNCE) United States $0.313B 0.00
Translate Bio (TBIO) United States $0.307B 0.00
Majesco Entertainment (PTE) United States $0.269B 0.00
Affimed (AFMD) Germany $0.266B 0.00
IMV INC (IMV) Canada $0.254B 0.00
Opexa Therapeutics (ACER) United States $0.249B 0.00
Lannett Co Inc (LCI) United States $0.233B 2.03
Tyme Technologies (TYME) United States $0.232B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Ocular Therapeutix (OCUL) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.212B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.205B 0.00
Calithera Biosciences (CALA) United States $0.197B 0.00
Neon Therapeutics (NTGN) United States $0.197B 0.00
ElectroCore (ECOR) United States $0.192B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.186B 0.00
Ardelyx (ARDX) United States $0.186B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.181B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 0.00
Molecular Templates (MTEM) United States $0.173B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
ContraFect (CFRX) United States $0.166B 0.00
MediWound (MDWD) Israel $0.162B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.151B 0.00
DURECT (DRRX) United States $0.144B 0.00
Jounce Therapeutics (JNCE) United States $0.144B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Melinta Therapeutics (MLNT) United States $0.139B 0.00
Champions Oncology (CSBR) United States $0.139B 0.00
Adherex Technologies (FENC) United States $0.137B 0.00
ProNAi Therapeutics (SRRA) Canada $0.127B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.123B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.122B 0.00
Cardiome Pharma (CORV) Canada $0.113B 0.00
Rafael Holdings (RFL) United States $0.109B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
CTI BioPharma (CTIC) United States $0.098B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.097B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.088B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.080B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Achaogen (AKAO) United States $0.076B 0.00
Nivalis Therapeutics (ALPN) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.070B 6.85
KemPharm (KMPH) United States $0.067B 0.00
Immune Design (IMDZ) United States $0.066B 0.00
Novan (NOVN) United States $0.063B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Forward Pharma (FWP) Denmark $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 36.93
Avenue Therapeutics (ATXI) United States $0.059B 0.00
Neos Therapeutics (NEOS) United States $0.058B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.053B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Capnia (SLNO) United States $0.045B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Trillium Therapeutics (TRIL) Canada $0.043B 0.00
Heat Biologics (HTBX) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
Lipocine (LPCN) United States $0.031B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
Biomerica (BMRA) United States $0.027B 0.00
IsoRay (ISR) United States $0.026B 0.00
NanoViricides (NNVC) United States $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.025B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 6.75
ESSA Pharma (EPIX) Canada $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Shineco (TYHT) China $0.016B 1.60
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00